In the one completed outcomes trial to date – the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial – in aortic stenosis patients, ezetimibe plus statin therapy did not reduce the ...
FH is a genetic condition of very high cholesterol levels that presents a high risk for coronary artery disease.
In the one completed outcomes trial to date – the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial – in aortic stenosis patients, ezetimibe plus statin therapy did not reduce the ...
FH is a genetic condition of very high cholesterol levels that presents a high risk for coronary artery disease.
Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...
I am a 69-year-old woman who was diagnosed with familial hypercholesterolemia (FH). I used statins for over a decade but developed vulvar lichen sclerosus (LS), which only went away when I stopped the ...
It usually includes high-dose statin drugs, which reduce the amount of cholesterol your body makes. It is often combined with ezetimibe, which blocks the absorption of cholesterol from food.
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam” or the "Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...
non-intensive statin) analysis. Results: The data of 179 patients receiving statins and/or ezetimibe, 50 of which with evolucumab and 129 without, were analyzed. Evolocumab add-on therapy over six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback